ck0801
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 31, 2019 (NCT03773328)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T cellSupplementation
T cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03773393 | Phase 1 | May 30, 2019 | Cellenkos, Inc., University of Texas at Houston |
| NCT03773328 | Phase 1 | Mar 31, 2019 | Cellenkos, Inc., University of Texas at Houston |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cellenkos, Inc. | For profit | 2 | 2 | 1 | 2019 |
| University of Texas at Houston | Academic/Hospital | 2 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1